Bioalpha Holdings Bhd (XKLS:0179) Other Financing: RM1.29 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bioalpha Holdings Bhd Other Financing?

Bioalpha Holdings Bhd XKLS:0179 Other Financing is RM1.29 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Bioalpha Holdings Bhd's Other Financing for the three months ended in Mar. 2026 was RM-0.04 Mil.

Bioalpha Holdings Bhd's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was RM1.29 Mil.

Bioalpha Holdings Bhd Other Financing Historical Data

* Premium members only.

The historical data trend for Bioalpha Holdings Bhd's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioalpha Holdings Bhd Other Financing Chart

Bioalpha Holdings Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.97 -0.79 6.94 -2.67 1.28

Bioalpha Holdings Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.04 -0.06 1.43 -0.04

Bioalpha Holdings Bhd Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM1.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of RM1.29 Mil mean?
Bioalpha Holdings Bhd (XKLS:0179) has a Other Financing of RM1.29 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Bioalpha Holdings Bhd and its competitors.
Is Bioalpha Holdings Bhd's Other Financing too high?
Bioalpha Holdings Bhd's current Other Financing is RM1.29 Mil.
How does Bioalpha Holdings Bhd's Other Financing compare to KHC and GIS?
Bioalpha Holdings Bhd's Other Financing of RM1.29 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Consumer Packaged Goods company?
A good Other Financing depends on the Consumer Packaged Goods industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Bioalpha Holdings Bhd and its competitors. Bioalpha Holdings Bhd's current Other Financing is RM1.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioalpha Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Bioalpha Holdings Bhd (XKLS:0179) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.02 — trading 100% above its estimated fair value. The current Other Financing is RM1.29 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Bioalpha Holdings Bhd (XKLS:0179), the current Other Financing is RM1.29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioalpha Holdings Bhd Business Description

Address No. 1, Jalan Perindustrian Suntrack, Hub Perindustrian Suntrack, Bandar Baru Bangi, Off Jalan P1A, Seksyen 13, Kajang, SGR, MYS, 43000
Bioalpha Holdings Bhd is a nutraceutical and health supplement group in Malaysia, operates a multi-faceted value chain that includes agricultural development, research and development (R&D), and the manufacturing of functional food and supplement products on an Original Design Manufacturer (ODM) basis. The business operates in segments that include Trading, Manufacturing, Retail pharmacy, and Others. It generates maximum revenue from Manufacturing segment, which involves Research, development, manufacture, importer, exporter, distribution and trader of nutritional and health care products. Geographically, the company derives majority revenue from Malaysia, while it also has its presence in China and Others.